Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 118Lymphoid 82Other hematologic neoplasm 61Breast 10Genitourinary 7Myeloid 6Thoracic 5Dermatologic 5Gynecologic 3Gastrointestinal 3CNS 3Sarcoma 2Other 2Head & Neck 2Tumor-Agnostic 1Other solid neoplasm 1Other neoplasm 1

Conditions

Vomiting 2Sarcoma 2Nausea 2Neoplasms 1

Interventions

Temozolomide 63Cyclophosphamide 55Radiotherapy 53Bevacizumab 50Doxorubicin 48Ifosfamide 33pazopanib 28fludarabine phosphate 28Etoposide 27Radiation 24Gemcitabine 24pembrolizumab 23Sirolimus 23Sunitinib 22Filgrastim 22Irinotecan 21Whole-Body Irradiation 20Peripheral Blood Stem Cell Transplantation 20Mycophenolic Acid 20Imatinib Mesylate 20Vincristine 19Magnetic Resonance Spectroscopy 18Sorafenib 16Methotrexate 16Busulfan 16Melphalan 15Carboplatin 15Docetaxel 14Cyclosporine 14temsirolimus 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Calcium Dobesilate × Sarcoma × Clear all
NCT01490060 2016-04-11

Fosaprepitant in Patients Receiving Ifosfamide-based Regimen

M.D. Anderson Cancer Center

Phase NA Completed
47 enrolled 6 charts
Sarcoma

Nausea, Neoplasms, Sarcoma, Vomiting

NCT00410488 2013-03-22

Palonosetron in Sarcoma Patients Receiving Chemotherapy With Adriamycin and Ifosfamide (AI)

M.D. Anderson Cancer Center

Phase NA Completed
51 enrolled 5 charts
Sarcoma

Nausea, Sarcoma, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡